Vaccine immunotherapy for immune suppressed patients

Details Vaccine immunotherapy for immune suppressed patients Vaccine immunotherapy for immune suppressed patients

2006-12-26

2006-12-26

Lankford, L Blaine (Department: 1651)

Drug, bio-affecting and body treating compositions

Lymphokine

Interleukin

C424S085100, C424S085400, C424S085500, C514S002600, C514S110000, C514S420000

Reexamination Certificate

active

07153499

ABSTRACT:
The present invention provides a formulation for inhibiting metastasis which includes 150–600 units of IL-2, a nonsteroidal anti-inflammatory drug (NSAID), and cyclophosphamide. The present invention further provides a formulation for inhibiting metastasis that includes IL-1, IL-2, IL-6, IL-8, δ-IFN and TNF-α.

REFERENCES:
patent: 5098702 (1992-03-01), Zimmerman et al.
patent: 5100664 (1992-03-01), Doyle et al.
patent: 5503841 (1996-04-01), Doyle et al.
patent: 5626838 (1997-05-01), Cavanaugh, Jr.
patent: 5632983 (1997-05-01), Hadden
patent: 5643565 (1997-07-01), Doyle et al.
patent: 5698194 (1997-12-01), Hadden
patent: 5773006 (1998-06-01), Anderson et al.
patent: 5800810 (1998-09-01), Doyle et al.
patent: 5830452 (1998-11-01), Bauer et al.
patent: 6060068 (2000-05-01), Doyle et al.
patent: 2002/0034494 (2002-03-01), Vicari et al.
patent: 0 974 357 (1998-07-01), None
Meneses, Abelardo, et al., “Histologic Findings in Patients with Head and Neck Squamous Cell Carcinoma Receiving Perilymphatic Natural Cytokine Mixture (IRX-2) Prior to Surgery,”Arch Pathol Lab Med, vol. 122:447-454 (1998).
Hadden, John W. et al., “Interleukins and Contrasuppression Induce Immune Regression of Head and Neck Cancer,”Arch Otolaryngol Head Neck Surg., vol. 120:395-403 (1994).
Hadden, J. et al., “A trial of IRX-2 in patents with squamous cell carcinomas of the head and neck,”International Immunopharmacology, 3:1073-1081 (2003).
Barrera, Jose Luis, et al., “Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck,”Archives of Otolaryngology—Head&Neck Surgery, 126.3:345-351 (2000).

Affiliated with

Also associated with

Rating

Vaccine immunotherapy for immune suppressed patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine immunotherapy for immune suppressed patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine immunotherapy for immune suppressed patients will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3683081